The Independent Voice of
European Private Equity

Advanced Search

Albion Ventures sells stake in Haemostatix to Ergomed

Lucy White 25 May 2016

Albion Ventures has sold its stake in Haemostatix, a topical blood clotting drug developer, to clinical development company Ergomed.

Ergomed

Related Articles

VC performance hits new high

23/07/19

Waterland-backed Median makes two deals

23/07/19

LBO France makes investment in Ecritel

23/07/19

Agilitas-backed Hydro makes second bolt-on

23/07/19

Innova Capital buys Optiplaza

23/07/19

Maven invests in computing company ebb3

23/07/19